ARCHIVES

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

Fox Chase Forms Network Of Oncologists

February 9, 1996

New Report On Survival Data Available From NCI

July 25, 1975

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993